Reuters: Hot Stocks: Albany Molecular says Bristol-Myers stops development of depression drug

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

The Best Way to Manage your Money. Start using Mint today to set a budget, track your goals and do more with your money. From our sponsors

Albany Molecular says Bristol-Myers stops development of depression drug Aug 12th 2013, 17:41 Mon Aug 12, 2013 1:41pm EDT Aug 12 (Reuters) - Albany Molecular Research Inc said partner Bristol-Myers Squibb Co would stop developing their experimental depression therapy. Albany's shares tumbled 19 percent to $10.24 in afternoon trading. Albany said Bristol-Myers stopped two mid-stage studies of the drug after it failed to show superiority over two other antidepressants. (link.reuters.com/fax32v) Albany said the decision would not have an impact on its forecasts for the third quarter and 2013. (Reporting by Pallavi Ail in Bangalore; Editing by Saumyadeb Chakrabarty)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions